Intuitive Surgical, Inc. $ISRG Shares Bought by PFG Advisors

PFG Advisors boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.2% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 10,075 shares of the medical equipment provider’s stock after purchasing an additional 1,093 shares during the quarter. PFG Advisors’ holdings in Intuitive Surgical were worth $4,506,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of ISRG. Rossmore Private Capital increased its stake in shares of Intuitive Surgical by 2.0% in the third quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock worth $446,000 after acquiring an additional 20 shares during the period. Activest Wealth Management raised its holdings in shares of Intuitive Surgical by 21.7% during the third quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock worth $50,000 after purchasing an additional 20 shares during the last quarter. Vertex Planning Partners LLC lifted its position in Intuitive Surgical by 2.3% during the second quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock valued at $498,000 after purchasing an additional 21 shares during the period. Accredited Investors Inc. lifted its position in Intuitive Surgical by 2.0% during the third quarter. Accredited Investors Inc. now owns 1,060 shares of the medical equipment provider’s stock valued at $474,000 after purchasing an additional 21 shares during the period. Finally, SPC Financial Inc. boosted its holdings in Intuitive Surgical by 1.3% in the third quarter. SPC Financial Inc. now owns 1,614 shares of the medical equipment provider’s stock valued at $722,000 after purchasing an additional 21 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, EVP Myriam Curet sold 421 shares of the company’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $208,378.16. Following the completion of the transaction, the executive vice president directly owned 409 shares of the company’s stock, valued at $202,438.64. This represents a 50.72% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Gary S. Guthart sold 2,800 shares of the stock in a transaction that occurred on Tuesday, January 27th. The shares were sold at an average price of $531.52, for a total value of $1,488,256.00. Following the transaction, the director owned 15,720 shares in the company, valued at $8,355,494.40. This trade represents a 15.12% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 37,261 shares of company stock valued at $19,690,721. 0.70% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. The Goldman Sachs Group reaffirmed a “buy” rating and set a $714.00 price target on shares of Intuitive Surgical in a research report on Friday, January 9th. Argus decreased their price objective on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a report on Wednesday, February 4th. Raymond James Financial upped their target price on Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a research note on Friday, January 23rd. Royal Bank Of Canada raised their target price on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Finally, TD Cowen upgraded Intuitive Surgical to a “strong-buy” rating in a research report on Tuesday, January 27th. Two research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $615.86.

Intuitive Surgical Stock Up 0.7%

NASDAQ:ISRG opened at $493.53 on Tuesday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $603.88. The stock’s 50-day moving average price is $520.00 and its 200-day moving average price is $512.68. The stock has a market capitalization of $175.27 billion, a PE ratio of 62.55, a price-to-earnings-growth ratio of 3.78 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.Intuitive Surgical’s quarterly revenue was up 18.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.21 EPS. Sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.